APA

Zhao Z., Li X., El-Battrawy I., Lan H., Zhong R., Xu Q., Huang M., Liao Z., Lang S., Zimmermann W., Cyganek L., Wieland T., Akin I., Zhou X. & Borggrefe M. (20200511). Drug Testing in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1. : Clinical pharmacology and therapeutics.

Chicago

Zhao Zhihan, Li Xin, El-Battrawy Ibrahim, Lan Huan, Zhong Rujia, Xu Qiang, Huang Mengying, Liao Zhenxing, Lang Siegfried, Zimmermann Wolfram-Hubertus, Cyganek Lukas, Wieland Thomas, Akin Ibrahim, Zhou Xiao-Bo and Borggrefe Martin. 20200511. Drug Testing in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1. : Clinical pharmacology and therapeutics.

Harvard

Zhao Z., Li X., El-Battrawy I., Lan H., Zhong R., Xu Q., Huang M., Liao Z., Lang S., Zimmermann W., Cyganek L., Wieland T., Akin I., Zhou X. and Borggrefe M. (20200511). Drug Testing in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1. : Clinical pharmacology and therapeutics.

MLA

Zhao Zhihan, Li Xin, El-Battrawy Ibrahim, Lan Huan, Zhong Rujia, Xu Qiang, Huang Mengying, Liao Zhenxing, Lang Siegfried, Zimmermann Wolfram-Hubertus, Cyganek Lukas, Wieland Thomas, Akin Ibrahim, Zhou Xiao-Bo and Borggrefe Martin. Drug Testing in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1. : Clinical pharmacology and therapeutics. 20200511.